The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Clinical and Experimental Applications of Sodium Phenylbutyrate
Open accessAbstract
Histone acetyltransferase and histone deacetylase are enzymes responsible for histone acetylation and deacetylation, respectively, in which the histones are acetylated and deacetylated on lysine residues in the N-terminal tail and on the surface of the nucleosome core. These processes are considered the most important epigenetic mechanisms for remodeling the chromatin structure and controlling the gene expression. Histone acetylation is associated with gene activation. Sodium phenylbutyrate is a histone deacetylase inhibitor that has been approved for treatement of urea cycle disorders and is under investigation in cancer, hemoglobinopathies, motor neuron diseases, and cystic fibrosis clinical trials. Due to its characteristics, not only of histone deacetylase inhibitor, but also of ammonia sink and chemical chaperone, the interest towards this molecule is growing worldwide. This review aims to update the current literature, involving the use of sodium phenylbutyrate in experimental studies and clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
Bensimon, G., Lacomblez, L., & Meininger, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300901 · Cited by 2,233
Rowland, L. P., & Shneider, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442207 · Cited by 1,812
From charcot to lou gehrig: deciphering selective motor neuron death in als
Cleveland, D. W., & Rothstein, J. D. (2001) · Nature Reviews Neuroscience · doi:10.1038/35097565 · Cited by 1,389
Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
Degradation of CFTR by the ubiquitin-proteasome pathway
Ward, C. L., Omura, S., & Kopito, R. R. (1995) · Cell · doi:10.1016/0092-8674(95)90240-6 · Cited by 1,304
Prognostic factors in ALS: A critical review
Chiò, A., Logroscino, G., Hardiman, O., Swingler, R., Mitchell, D., Beghi, E., Traynor, B. G., & On Behalf of the Eurals Consortium (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960802566824 · Cited by 1,172
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
Marks, P. A., Richon, V. M., & Rifkind, R. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1210 · Cited by 1,157
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R. G., Mitchell, J. D., & Moore, D. H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447.pub3 · Cited by 1,058
Retinal ischemia: mechanisms of damage and potential therapeutic strategies
Osborne, N. N., Casson, R. J., Wood, J. P. M., Chidlow, G., Graham, M., & Melena, J. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2003.12.001 · Cited by 1,056
Lunn, M. R., & Wang, C. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60921-6 · Cited by 995
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R., Mitchell, J., Lyon, M., & Moore, D. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447 · Cited by 909
What's Up and Down with Histone Deacetylation and Transcription?
Pazin, M. J., & Kadonaga, J. T. (1997) · Cell · doi:10.1016/s0092-8674(00)80211-1 · Cited by 821
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
Kazantsev, A. G., & Thompson, L. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2681 · Cited by 711
Ferrante, R. J., Kubilus, J. K., Lee, J., Ryu, H., Beesen, A., Zucker, B., Smith, K., Kowall, N. W., Ratan, R. R., Luthi-Carter, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09418.2003 · Cited by 693
Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies
Urdinguio, R. G., Sanchez-Mut, J. V., & Esteller, M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70262-5 · Cited by 582
W. H. Fox Talbot and the history of photography
Gernsheim, H. (1977) · Endeavour · doi:10.1016/0160-9327(77)90005-9 · Cited by 564
Zerres, K. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540290108025 · Cited by 563
The Human Histone Deacetylase Family
Gray, S. G., & Ekström, T. J. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5080 · Cited by 546
CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTS
Drummond, D. C., Noble, C. O., Kirpotin, D. B., Guo, Z., Scott, G. K., & Benz, C. C. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095825 · Cited by 494
Bcl-2: Prolonging Life in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis
Kostic, V., Jackson-Lewis, V., de Bilbao, F., Dubois-Dauphin, M., & Przedborski, S. (1997) · Science · doi:10.1126/science.277.5325.559 · Cited by 482
Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression
Bueno, M. J., Pérez de Castro, I., Gómez de Cedrón, M., Santos, J., Calin, G. A., Cigudosa, J. C., Croce, C. M., Fernández-Piqueras, J., & Malumbres, M. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.013 · Cited by 467
Induction of erythroid differentiation in the human leukaemia cell line K562
ANDERSSON, L. C., JOKINEN, M., & GAHMBERG, C. G. (1979) · Nature · doi:10.1038/278364a0 · Cited by 466
Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression
Bueno, M. J., Pérez de Castro, I., Gómez de Cedrón, M., Santos, J., Calin, G. A., Cigudosa, J. C., Croce, C. M., Fernández-Piqueras, J., & Malumbres, M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.018 · Cited by 457
COMMENTARY: Role of connexin genes in growth control
Yamasaki, H., & Naus, C. C. G. (1996) · Carcinogenesis · doi:10.1093/carcin/17.6.1199 · Cited by 456
Gardian, G., Browne, S. E., Choi, D.-K., Klivenyi, P., Gregorio, J., Kubilus, J. K., Ryu, H., Langley, B., Ratan, R. R., Ferrante, R. J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410210200 · Cited by 456
Epigenetic regulation of microRNA expression in colorectal cancer
Bandres, E., Agirre, X., Bitarte, N., Ramirez, N., Zarate, R., Roman‐Gomez, J., Prosper, F., & Garcia‐Foncillas, J. (2009) · International Journal of Cancer · doi:10.1002/ijc.24638 · Cited by 439
Ricobaraza, A., Cuadrado-Tejedor, M., Pérez-Mediavilla, A., Frechilla, D., Del Río, J., & García-Osta, A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.229 · Cited by 423
Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease
Borovecki, F., Lovrecic, L., Zhou, J., Jeong, H., Then, F., Rosas, H. D., Hersch, S. M., Hogarth, P., Bouzou, B., Jensen, R. V., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504921102 · Cited by 414
Treatment of spinal muscular atrophy by sodium butyrate
Chang, J.-G., Hsieh-Li, H.-M., Jong, Y.-J., Wang, N. M., Tsai, C.-H., & Li, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171105098 · Cited by 404
Nakano, K., Mizuno, T., Sowa, Y., Orita, T., Yoshino, T., Okuyama, Y., Fujita, T., Ohtani-Fujita, N., Matsukawa, Y., Tokino, T., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22199 · Cited by 395
Chemical mechanisms of histone lysine and arginine modifications
Smith, B. C., & Denu, J. M. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2008.06.005 · Cited by 390 · cited 1×
“human diseases, including arthritis, cancer, heart disease, diabetes mellitus, and neurodegenerative disorders.([5]) In particular, histone acetyl transferases (HATs) and histone deacetylases (HDACs) are responsible for the histone being acetylated or deacetylated (removal of an acetyl group from the e-amino groups of…”
BackgroundRubenstein, R. C., Egan, M. E., & Zeitlin, P. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119788 · Cited by 389
Ryu, H., Smith, K., Camelo, S. I., Carreras, I., Lee, J., Iglesias, A. H., Dangond, F., Cormier, K. A., Cudkowicz, M. E., H. Brown, R., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03077.x · Cited by 353
Calcium signaling in neurodegeneration
Marambaud, P., Dreses-Werringloer, U., & Vingtdeux, V. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-20 · Cited by 352
RUBENSTEIN, R. C., & ZEITLIN, P. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9706088 · Cited by 340
Histone deacetylase inhibitors
Monneret, C. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.10.001 · Cited by 338
Leigh, P. N., & Ray-Chaudhuri, K. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.8.886 · Cited by 331
Genetics of motor neuron disorders: new insights into pathogenic mechanisms
Dion, P. A., Daoud, H., & Rouleau, G. A. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2680 · Cited by 313
Bruijn, L. I., Beal, M. F., Becher, M. W., Schulz, J. B., Wong, P. C., Price, D. L., & Cleveland, D. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7606 · Cited by 288
Rubenstein, R. C., & Zeitlin, P. L. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.278.2.c259 · Cited by 269
Sodium 4-Phenylbutyrate Protects against Cerebral Ischemic Injury
Qi, X., Hosoi, T., Okuma, Y., Kaneko, M., & Nomura, Y. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001339 · Cited by 263
Long-Term Treatment of Girls with Ornithine Transcarbamylase Deficiency
Maestri, N. E., Brusilow, S. W., Clissold, D. B., & Bassett, S. S. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609193351204 · Cited by 258
Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy
Andreassi, C., Angelozzi, C., Tiziano, F. D., Vitali, T., De Vincenzi, E., Boninsegna, A., Villanova, M., Bertini, E., Pini, A., Neri, G., et al. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201102 · Cited by 255
Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy
Kemp, S., Wei, H.-M., Lu, J.-F., Braiterman, L. T., McGuinness, M. C., Moser, A. B., Watkins, P. A., & Smith, K. D. (1998) · Nature Medicine · doi:10.1038/3242 · Cited by 249
Lee, S. W., Tomasetto, C., Paul, D., Keyomarsi, K., & Sager, R. (1992) · The Journal of cell biology · doi:10.1083/jcb.118.5.1213 · Cited by 240
Novel mechanisms of apoptosis induced by histone deacetylase inhibitors.
Peart, M. J., Tainton, K. M., Ruefli, A. A., Dear, A. E., Sedelies, K. A., O’Reilly, L. A., Waterhouse, N. J., Trapani, J. A., & Johnstone, R. W. (2003) · PubMed · Cited by 233
Dover, G., Brusilow, S., & Charache, S. (1994) · Blood · doi:10.1182/blood.v84.1.339.339 · Cited by 232
Histone deacetylase as a new target for cancer chemotherapy
Yoshida, M., Furumai, R., Nishiyama, M., Komatsu, Y., Nishino, N., & Horinouchi, S. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100300 · Cited by 215
Huang, L., Sowa, Y., Sakai, T., & Pardee, A. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203963 · Cited by 209
Gilbert, J., Baker, S. D., Bowling, M. K., Grochow, L. B., Figg, W. D., Zabelina, Y., Donehower, R. C., & Carducci, M. A. (2001) · PubMed · Cited by 206
Carducci, M. A., Gilbert, J., Bowling, M. K., Noe, D. A., Eisenberger, M. A., Sinibaldi, V. J., Zabelina, Y., Chen, T., Grochow, L. B., & Donehower, R. C. (2001) · PubMed · Cited by 202
Blagosklonny, M. V., Robey, R. W., Sackett, D. L., Du, L., Traganos, F., Darżynkiewicz, Z., Fojo, T., & Bates, S. E. (2002) · PubMed · Cited by 199
In Vitro Reactivation of the FMR1 Gene Involved in Fragile X Syndrome
Chiurazzi, P., Pomponi, M. G., Willemsen, R., Oostra, B. A., & Neri, G. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.1.109 · Cited by 198
Xiao, C., Giacca, A., & Lewis, G. F. (2011) · Diabetes · doi:10.2337/db10-1433 · Cited by 197
Evidence of CFTR Function in Cystic Fibrosis after Systemic Administration of 4-Phenylbutyrate
Zeitlin, P. L., Diener-West, M., Rubenstein, R. C., Boyle, M. P., Lee, C. K. K., & Brass-Ernst, L. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0639 · Cited by 194
Chromatin Remodeling and Leukemia: New Therapeutic Paradigms
Redner, R. L., Wang, J., & Liu, J. M. (1999) · Blood · doi:10.1182/blood.v94.2.417 · Cited by 189
Leonard, J. V., & Morris, A. A. M. (2002) · Seminars in Neonatology · doi:10.1053/siny.2001.0085 · Cited by 188
Tsui, L.-C. (1992) · Human Mutation · doi:10.1002/humu.1380010304 · Cited by 177
A Review of Depsipeptide and Other Histone Deacetylase Inhibitors in Clinical Trials
Piekarz, R., & Bates, S. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383980 · Cited by 174
Kubota, K., Niinuma, Y., Kaneko, M., Okuma, Y., Sugai, M., Omura, T., Uesugi, M., Uehara, T., Hosoi, T., & Nomura, Y. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03782.x · Cited by 172
Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders
Grayson, D. R., Kundakovic, M., & Sharma, R. P. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.061333 · Cited by 171
Phenylacetylglutamine May Replace Urea as a Vehicle for Waste Nitrogen Excretion
Brusilow, S. W. (1991) · Pediatric Research · doi:10.1203/00006450-199102000-00009 · Cited by 169
Vukosavic, S., Stefanis, L., Jackson-Lewis, V., Guégan, C., Romero, N., Chen, C., Dubois-Dauphin, M., & Przedborski, S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09119.2000 · Cited by 166
Petri, S., Kiaei, M., Kipiani, K., Chen, J., Calingasan, N. Y., Crow, J. P., & Beal, M. F. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.09.013 · Cited by 161
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
RG, M., JD, M., M, L., & DH, M. (2003) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820310002601 · Cited by 159
Yokota, N., Mainprize, T. G., Taylor, M. D., Kohata, T., Loreto, M., Ueda, S., Dura, W., Grajkowska, W., Kuo, J. S., & Rutka, J. T. (2004) · Oncogene · doi:10.1038/sj.onc.1207475 · Cited by 158
Phase 2 study of sodium phenylbutyrate in ALS
Cudkowicz, M., Andres, P. L., MacDonald, S., Bedlack, R., Choudry, R., Brown, R. H., Jr., Zhang, H., Schoenfeld, D., Shefner, J. M., Matson, S. A., et al. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802320487 · Cited by 154
Gore, S. D., Weng, L.-J., Figg, W. D., Zhai, S., Donehower, R. C., Dover, G. H., Grever, M. R., Griffin, C. A., Grochow, L. B., Hawkins, A. L., et al. (2002) · PubMed · Cited by 151
Suppression of human prostate cancer cell growth by forced expression of connexin genes
Mehta, P. P., Perez‐Stable, C., Nadji, M., Mian, M., Asotra, K., & Roos, B. A. (1999) · Developmental Genetics · doi:10.1002/(sici)1520-6408(1999)24:1/2<91::aid-dvg10>3.0.co;2-# · Cited by 145
Vilatobá, M., Eckstein, C. P., Bilbao, G., Smyth, C. A., Jenkins, S. M., Thompson, J. A., Eckhoff, D. E., & Contreras, J. L. (2005) · Surgery · doi:10.1016/j.surg.2005.04.019 · Cited by 145
Phenylacetate: a novel nontoxic inducer of tumor cell differentiation.
Samid, D., Shack, S., & Sherman, L. T. (1992) · PubMed · Cited by 144
Hauke, J., Rießland, M., Lunke, S., Eyüpoglu, I. Y., Blümcke, I., El‐Osta, A., Wirth, B., & Hahnen, E. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn357 · Cited by 143
Ginder, G. D., Whitters, M. J., & Pohlman, J. K. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.13.3954 · Cited by 136
Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia.
Lagrèze, W. A., Knörle, R., Bach, M., & Feuerstein, T. J. (1998) · PubMed · Cited by 132
Perrine, S. P., Miller, B., Faller, D. V., Cohen, R., Vichinsky, E. P., Hurst, D., Lubin, B. H., & Papayannopoulou, T. (1989) · Blood · doi:10.1182/blood.v74.1.454.454 · Cited by 126
Increased Fetal Hemoglobin in Patients Receiving Sodium 4-Phenylbutyrate
Dover, G., Brusilow, S. W., & Samid, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208203270818 · Cited by 125
Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching.
Perrine, S. P., Rudolph, A. M., Faller, D. V., Roman, C., Cohen, R. A., Chen, S., & Kan, Y. W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.22.8540 · Cited by 120
Constantoulakis, P., Knitter, G. H., & Stamatoyannopoulos, G. (1989) · Blood · doi:10.1182/blood.v74.6.1963.1963 · Cited by 113
Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice
Signore, S. J. D., Amante, D. J., Kim, J.-H., Stack, E. C., Goodrich, S., Cormier, K., Smith, K., Cudkowicz, M., & Ferrante, R. J. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802226148 · Cited by 111
Genetic Factors Affecting Clinical Severity in β-Thalassemia Syndromes
Winichagoon, P., Fucharoen, S., Chen, P., & Wasi, P. (2000) · The American journal of pediatric hematology/oncology · doi:10.1097/00043426-200011000-00026 · Cited by 108
Hauswald, S., Duque‐Afonso, J., Wagner, M. M., Schertl, F. M., Lübbert, M., Peschel, C., Keller, U. B., & Licht, T. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2048 · Cited by 107
Amyotrophic Lateral Sclerosis: Pathogenesis
Robert H. Brown, Jr., & Robberecht, W. (2001) · Seminars in Neurology · doi:10.1055/s-2001-15260 · Cited by 104
Scaglia, F., Carter, S., O’Brien, W. E., & Lee, B. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.11.017 · Cited by 103
Phenylbutyrate, a histone deacetylase inhibitor, protects against Adriamycin-induced cardiac injury
Daosukho, C., Chen, Y., Noel, T. J., Sompol, P. M., Nithipongvanitch, R., Velez, J. M., Oberley, T. D., & Clair, D. K. S. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.007 · Cited by 102
Ornithine transcarbamylase deficiency: a urea cycle defect
Gordon, N. (2003) · European Journal of Paediatric Neurology · doi:10.1016/s1090-3798(03)00040-0 · Cited by 101
Fibach, E., Prasanna, P., Rodgers, G., & Samid, D. (1993) · Blood · doi:10.1182/blood.v82.7.2203.2203 · Cited by 101
Spira, A. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00081-x · Cited by 101
Regulation of lifespan by histone deacetylase
Chang, K. T., & Min, K. (2002) · Ageing Research Reviews · doi:10.1016/s1568-1637(02)00003-x · Cited by 100
Phenylbutyrate therapy for maple syrup urine disease
Brunetti‐Pierri, N., Lanpher, B. C., Erez, A., Ananieva, E. A., Islam, M. M., Marini, J. C., Sun, Q., Yu, C., Hegde, M., Li, J., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq507 · Cited by 98
Atwal, R. S., & Truant, R. (2008) · Autophagy · doi:10.4161/auto.5201 · Cited by 94
Problems in the management of urea cycle disorders
Wilcken, B. M. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.10.016 · Cited by 93
Defective Trafficking of Nephrin Missense Mutants Rescued by a Chemical Chaperone
Liu, X., Doné, S. C., Yan, K., Kilpeläinen, P., Pikkarainen, T., & Tryggvason, K. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000129826.28932.fd · Cited by 91
Phuphanich, S., Baker, S. D., Grossman, S. A., Carson, K. A., Gilbert, M. R., Fisher, J. D., & Carducci, M. A. (2005) · Neuro-Oncology · doi:10.1215/s1152851704000183 · Cited by 91
Vitamin B3 and sirtuin function
Denu, J. M. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.07.004 · Cited by 90
Sodium phenylbutyrate in Huntington's disease: A dose‐finding study
Hogarth, P., Lovrečić, L., & Krainc, D. (2007) · Movement Disorders · doi:10.1002/mds.21632 · Cited by 89
Sodium 4-phenylbutyrate downregulates HSC 70 expression by facilitating mRNA degradation
Rubenstein, R. C., & Lyons, B. M. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.1.l43 · Cited by 88
Dasgupta, S., Zhou, Y., Jana, M., Banik, N. L., & Pahan, K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3874 · Cited by 87
Suppression of tumorigenicity of human lung carcinoma cells after transfection with connexin43
Zhang, Z. (1998) · Carcinogenesis · doi:10.1093/carcin/19.11.1889 · Cited by 86
(1995) · Paediatric and Perinatal Epidemiology · doi:10.1111/j.1365-3016.1995.tb00145.x · Cited by 84
Lin, J., Gilbert, J., Rudek, M. A., Zwiebel, J. A., Gore, S. D., Jiemjit, A., Zhao, M., Baker, S. D., Ambinder, R. F., Herman, J. G., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0567 · Cited by 83
Camacho, L. H., Olson, J., Tong, W. P., Young, C. W., Spriggs, D. R., & Malkin, M. G. (2006) · Investigational New Drugs · doi:10.1007/s10637-006-9017-4 · Cited by 81
Orkin, S. H., Swan, D., & Leder, P. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40736-9 · Cited by 80
Neurological outcome of patients with ornithine carbamoyltransferase deficiency
Nicolaides, P. (2002) · Archives of Disease in Childhood · doi:10.1136/adc.86.1.54 · Cited by 79
van der Velden, L. M., Stapelbroek, J. M., Krieger, E., van den Berghe, P. V. E., Berger, R., Verhulst, P. M., Holthuis, J. C. M., Houwen, R. H. J., Klomp, L. W. J., & van de Graaf, S. F. J. (2009) · Hepatology · doi:10.1002/hep.23268 · Cited by 77
Gore, S. D., Samid, D., & Weng, L. J. (1997) · PubMed · Cited by 74
Epigenetic Control Using Natural Products and Synthetic Molecules
Scior, T., & Garces-Eisele, S. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776361067 · Cited by 73
DiGiuseppe, J. A., Weng, L.-J., Yu, K.-H., Fu, S., Kastan, M., Samid, D., & Gore, S. D. (1999) · Leukemia · doi:10.1038/sj.leu.2401471 · Cited by 72
Lim, M., McKenzie, K. R., Floyd, A. D., Kwon, E., & Zeitlin, P. L. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0086oc · Cited by 70
alpha-Amino-N-butyric acid stimulates fetal hemoglobin in the adult
Constantoulakis, P., Papayannopoulou, T., & Stamatoyannopoulos, G. (1988) · Blood · doi:10.1182/blood.v72.6.1961.1961 · Cited by 68
Retinal Ganglion Cell Dysfunction Induced by Hypoxia and Glutamate
Gross, R. L., Hensley, S. H., Gao, F., et al. (1999) · Survey of Ophthalmology · doi:10.1016/s0039-6257(99)00054-5 · Cited by 68
Augmentation of antitumor effects of p53 Gene therapy by combination with HDAC inhibitor
Takimoto, R., Kato, J., Terui, T., et al. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.4.1620 · Cited by 67
Hanada, S., Harada, M., Kumemura, H., Omary, M. B., Koga, H., Kawaguchi, T., Taniguchi, E., Yoshida, T., Hisamoto, T., Yanagimoto, C., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.039 · Cited by 66
Singh, O. V., Pollard, H. B., & Zeitlin, P. L. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700303-mcp200 · Cited by 66
Egger, G., Aparicio, A. M., Escobar, S. G., & Jones, P. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2845 · Cited by 64
Legras, A., Labarthe, F., Maillot, F., Garrigue, M. A., Kouatchet, A., & de Baulny, H. O. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201000-00035 · Cited by 62
Disposition of Phenylbutyrate and its Metabolites, Phenylacetate and Phenylacetylglutamine
Piscitelli, S. C., Thibault, A., Figg, W. D., Tompkins, A. C., Headlee, D. J., Lieberman, R., Samid, D., & Myers, C. E. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04075.x · Cited by 61
Pharmacoproteomics of 4-Phenylbutyrate-Treated IB3-1 Cystic Fibrosis Bronchial Epithelial Cells
Singh, O. V., Vij, N., Mogayzel, P. J., Cathy, J., Pollard, H. B., & Zeitlin, P. L. (2006) · Journal of Proteome Research · doi:10.1021/pr050319o · Cited by 61
Fetal Globin Stimulant Therapies in the Beta-hemoglobinopathies: Principles and Current Potential
Perrine, S. P. (2008) · Pediatric Annals · doi:10.3928/00904481-20080501-10 · Cited by 60
Praphanproj, V., Boyadjiev, S. A., Waber, L. J., Brusilow, S. W., & Geraghty, M. T. (2000) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005661631281 · Cited by 59
Pelin, K., Hirvonen, A., & Linnainmaa, K. (1994) · Carcinogenesis · doi:10.1093/carcin/15.11.2673 · Cited by 59
Egler, V., Korur, S., Failly, M., Boulay, J., Imber, R., Lino, M. M., & Merlo, A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4182 · Cited by 59
Fetal hemoglobin induction with butyric acid: efficacy and toxicity
Blau, C., Constantoulakis, P., Shaw, C., & Stamatoyannopoulos, G. (1993) · Blood · doi:10.1182/blood.v81.2.529.529 · Cited by 58
Andersson, C., & Roomans, G. M. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.15e21.x · Cited by 56
Burkitt, K., & Ljungman, M. E. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-24 · Cited by 53
Ekström, T. J., Almqvist, P. M., & Svechnikova, I. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.4.821 · Cited by 52
Yamano, T., Ura, K., Morishita, R., Nakajima, H., Monden, M., & Kaneda, Y. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0074 · Cited by 51
Schultz, J., Ibrahim, S. M., Vera, J., & Kunz, M. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-53 · Cited by 50
Christov, K. T., Grubbs, C. J., Shilkaitis, A. L., Juliana, M. M., & Lubet, R. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0404 · Cited by 48
Shafer, S. Q. (1995) · Neurology · doi:10.1212/wnl.45.7.1431-a · Cited by 48
Riluzole for ALS: what is the evidence?
Miller, R. G. (2003) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820310012628 · Cited by 47
Activation of CFTR by genistein in human airway epithelial cell lines
Andersson, C., Servetnyk, Z., & Roomans, G. M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01436-0 · Cited by 47
Hurtubise, A., Bernstein, M. L., & Momparler, R. L. (2008) · Cancer Cell International · doi:10.1186/1475-2867-8-16 · Cited by 46
Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate
Svechnikova, I., Gray, S. G., Kundrotienė, J., Ponthan, F., Kogner, P., & Ekström, T. J. (2003) · PubMed · doi:10.25405/ncl.34250919 · Cited by 38
Cancer Chemoprevention by Connexins
Vine, A. L., & Bertram, J. S. (2002) · Cancer and Metastasis Reviews · doi:10.1023/a:1021250624933 · Cited by 36
Berg, S. L., Serabe, B. M., Aleksic, A., Bomgaars, L. R., McGuffey, L., Dauser, R., Durfee, J., Nuchtern, J. G., & Blaney, S. M. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800000256 · Cited by 35
Yu, K., Weng, L.-J., Fu, S., Piantadosi, S., & Gore, S. D. (1999) · Leukemia · doi:10.1038/sj.leu.2401468 · Cited by 35
Clinical trials in spinal muscular atrophy
Darras, B. T., & Kang, P. B. (2007) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3282f1884c · Cited by 34
Restoration of nitrogen homeostasis in a man with ornithine transcarbamylase deficiency
Brusilow, S. W., & Finkelstien, J. (1993) · Metabolism · doi:10.1016/0026-0495(93)90135-b · Cited by 32
Hattori, Y., Fukushima, M., & Maitani, Y. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.6.1427 · Cited by 32
Ebbel, E. N., Leymarie, N., Schiavo, S., Sharma, S., Gevorkian, S., Hersch, S. M., Matson, W. R., & Costello, C. E. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.01.010 · Cited by 32
Wakabayashi, K., Saito, H., Ebinuma, H., Saito, Y., Takagi, T., Nakamura, M., Umezawa, A., Hata, J., & Ishii, H. (2000) · Oncology Reports · doi:10.3892/or.7.2.285 · Cited by 30
Prulière-Escabasse, V., Planès, C., Escudier, E., Fanen, P., Coste, A., & Clérici, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702384200 · Cited by 30
MERZVINSKYTE, R., Treigytė, G., Savickienė, J., Magnusson, K., & Navakauskienė, R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.080 · Cited by 28
Ishiguro, K., & Sartorelli, A. C. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04157.x · Cited by 25
Histone deacetylase inhibitors in myelodysplastic syndrome
Bhalla, K. N., & List, A. F. (2004) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.011 · Cited by 24
Liu, L., Hudgins, R. W., Miller, A. C., Chen, L.-C., & Samid, D. (1995) · Cytokine · doi:10.1006/cyto.1995.0061 · Cited by 23
Verheul, H. M. W., Qian, D. Z., Carducci, M. A., & Пили, Р. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0379-2 · Cited by 19
p21waf1/Cip1 partially mediates apoptosis in hepatocellular carcinoma cells
Svechnikova, I., Ammerpohl, O., & Ekström, T. J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.222 · Cited by 18
Therapeutic strategies to correct malfunction of CFTR
Lim, M., & Zeitlin, P. L. (2001) · Paediatric Respiratory Reviews · doi:10.1053/prrv.2000.0124 · Cited by 17
Ryningen, A., Stapnes, C., & Bruserud, Ø. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.01.019 · Cited by 16
Dover, G. J. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10465.x · Cited by 15
Pharmacological reactivation of inactive genes: the fragile X experience
Chiurazzi, P., & Neri, G. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00571-8 · Cited by 12
Wang, C., Meng, M., Zhang, J., et al. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200809010-00023 · Cited by 12
Cited by
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Li, Y., & Seto, E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026831 · Cited by 1,284
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis
Zhang, Y.-G., Wu, S., Yi, J., Xia, Y., Jin, D., Zhou, J., & Sun, J. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.12.014 · Cited by 287
Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers
Quinn, J. P., Corbett, N. J., Kellett, K. A. B., & Hooper, N. M. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-170959 · Cited by 170
HDAC inhibitors: A new promising drug class in anti-aging research
Pasyukova, E. G., & Vaiserman, A. M. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.08.008 · Cited by 99
Metadata
- Authors
- Iannitti, T., & Palmieri, B.
- Venue
- Drugs in R & D
- Published
- 2011-09
- Volume
- 11
- Issue
- 3
- Pages
- 227-249
- ISSN
- 1174-5886 (ISSN-L)
- 1179-6901
- OpenAlex
- W2005629927
- Cited by
- 270
- References
- 157
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.